174 related articles for article (PubMed ID: 21435222)
1. Prognostic impact of CD168 expression in gastric cancer.
Ishigami S; Ueno S; Nishizono Y; Matsumoto M; Kurahara H; Arigami T; Uchikado Y; Setoyama T; Arima H; Yoshiaki K; Kijima Y; Kitazono M; Natsugoe S
BMC Cancer; 2011 Mar; 11():106. PubMed ID: 21435222
[TBL] [Abstract][Full Text] [Related]
2. The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder.
Niedworok C; Kretschmer I; Röck K; Vom Dorp F; Szarvas T; Heß J; Freudenberger T; Melchior-Becker A; Rübben H; Fischer JW
PLoS One; 2013; 8(9):e75681. PubMed ID: 24069434
[TBL] [Abstract][Full Text] [Related]
3. The Role of CD44 and RHAMM in Endometrial (Endometrioid Type) Cancer: An Immunohistochemical Study.
Klarić M; Haller H; Brnčić Fischer A; Babarović E; Prijić A; Eminović S
Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):606-612. PubMed ID: 29734248
[TBL] [Abstract][Full Text] [Related]
4. Receptor for hyaluronic acid-mediated motility (RHAMM, CD168) expression is prognostically important in both nodal negative and nodal positive large cell lung cancer.
Augustin F; Fiegl M; Schmid T; Pomme G; Sterlacci W; Tzankov A
J Clin Pathol; 2015 May; 68(5):368-73. PubMed ID: 25731190
[TBL] [Abstract][Full Text] [Related]
5. Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer.
Zhang Q; Ye Z; Yang Q; He X; Wang H; Zhao Z
World J Surg Oncol; 2012 Jun; 10():103. PubMed ID: 22681645
[TBL] [Abstract][Full Text] [Related]
6. Expression of the hyaluronan-mediated motility receptor RHAMM in tumor budding cells identifies aggressive colorectal cancers.
Koelzer VH; Huber B; Mele V; Iezzi G; Trippel M; Karamitopoulou E; Zlobec I; Lugli A
Hum Pathol; 2015 Nov; 46(11):1573-81. PubMed ID: 26351067
[TBL] [Abstract][Full Text] [Related]
7. Expression of EphA1 in gastric carcinomas is associated with metastasis and survival.
Wang J; Dong Y; Wang X; Ma H; Sheng Z; Li G; Lu G; Sugimura H; Zhou X
Oncol Rep; 2010 Dec; 24(6):1577-84. PubMed ID: 21042754
[TBL] [Abstract][Full Text] [Related]
8. Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients.
Tarullo SE; He Y; Daughters C; Knutson TP; Henzler CM; Price MA; Shanley R; Witschen P; Tolg C; Kaspar RE; Hallstrom C; Gittsovich L; Sulciner ML; Zhang X; Forster CL; Lange CA; Shats O; Desler M; Cowan KH; Yee D; Schwertfeger KL; Turley EA; McCarthy JB; Nelson AC
J Pathol; 2023 Jul; 260(3):289-303. PubMed ID: 37186300
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronan (HA) interacting proteins RHAMM and hyaluronidase impact prostate cancer cell behavior and invadopodia formation in 3D HA-based hydrogels.
Gurski LA; Xu X; Labrada LN; Nguyen NT; Xiao L; van Golen KL; Jia X; Farach-Carson MC
PLoS One; 2012; 7(11):e50075. PubMed ID: 23166824
[TBL] [Abstract][Full Text] [Related]
10. Redox Responsive Hyaluronic Acid Nanogels for Treating RHAMM (CD168) Over-expressive Cancer, both Primary and Metastatic Tumors.
Yang C; Li C; Zhang P; Wu W; Jiang X
Theranostics; 2017; 7(6):1719-1734. PubMed ID: 28529647
[TBL] [Abstract][Full Text] [Related]
11. Downregulated parafibromin expression is a promising marker for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Virchows Arch; 2008 Feb; 452(2):147-55. PubMed ID: 18080135
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Factors for Survival in Node-Negative Gastric Cancer Patients Who Underwent Curative Resection.
Zhou Y; Cui JG; Huang F; Zhang A; Li C; Zhao ZC; Li WD; Fu WH
Scand J Surg; 2017 Sep; 106(3):235-240. PubMed ID: 28376652
[TBL] [Abstract][Full Text] [Related]
13. [Expression tumor stem cell surface marker CD44 in gastric cancer and its significance].
Xie JW; Huang CM; Zheng CH; Li P; Wang JB; Lin JX; Lu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Nov; 16(11):1107-12. PubMed ID: 24277411
[TBL] [Abstract][Full Text] [Related]
14. Function and clinical relevance of RHAMM isoforms in pancreatic tumor progression.
Choi S; Wang D; Chen X; Tang LH; Verma A; Chen Z; Kim BJ; Selesner L; Robzyk K; Zhang G; Pang S; Han T; Chan CS; Fahey TJ; Elemento O; Du YN
Mol Cancer; 2019 May; 18(1):92. PubMed ID: 31072393
[TBL] [Abstract][Full Text] [Related]
15. Elevated FOXO6 expression correlates with progression and prognosis in gastric cancer.
Wang JH; Tang HS; Li XS; Zhang XL; Yang XZ; Zeng LS; Ruan Q; Huang YH; Liu GJ; Wang J; Cui SZ
Oncotarget; 2017 May; 8(19):31682-31691. PubMed ID: 28404958
[TBL] [Abstract][Full Text] [Related]
16. The clinicopathological and prognostic significance of MUC-1 expression in Japanese gastric carcinomas: an immunohistochemical study of tissue microarrays.
Li XH; Zheng HC; Wang ZG; Takahashi H; Yang XH; Guan YF; Takano Y
Anticancer Res; 2008; 28(2A):1061-7. PubMed ID: 18507055
[TBL] [Abstract][Full Text] [Related]
17. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
Zhang S; Li L; Lin JY; Lin H
World J Gastroenterol; 2003 May; 9(5):899-904. PubMed ID: 12717827
[TBL] [Abstract][Full Text] [Related]
18. Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: relevance with tumor progression.
Li H; Guo L; Li JW; Liu N; Qi R; Liu J
Int J Oncol; 2000 Nov; 17(5):927-32. PubMed ID: 11029494
[TBL] [Abstract][Full Text] [Related]
19. Expression of BMP-7 in human gastric cancer and its clinical significance.
Aoki M; Ishigami S; Uenosono Y; Arigami T; Uchikado Y; Kita Y; Kurahara H; Matsumoto M; Ueno S; Natsugoe S
Br J Cancer; 2011 Feb; 104(4):714-8. PubMed ID: 21224856
[TBL] [Abstract][Full Text] [Related]
20. The Receptor for Hyaluronan-Mediated Motility (CD168) promotes inflammation and fibrosis after acute lung injury.
Cui Z; Liao J; Cheong N; Longoria C; Cao G; DeLisser HM; Savani RC
Matrix Biol; 2019 May; 78-79():255-271. PubMed ID: 30098420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]